totally agree - Wilson stuff is just PR - the Bio presentation should have had "similar" output by management but a lot of good that did to the SP. and target now only $0.70 - wasn't it $1 not too long ago by another firm??. I don't take any notice of these target prices by brokers - all self interest IMO. and as for FDA - yes Mitta very interesting take.
totally agree - Wilson stuff is just PR - the Bio presentation...
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.001(1.79%) |
Mkt cap ! $15.98M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.5¢ | 5.5¢ | $3.097K | 56.31K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 168800 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 185000 | 2 |
View Market Depth
| Last trade - 13.06pm 10/09/2024 (20 minute delay) ? |
| ACR (ASX) Chart |